EBNA3A and EBNA3C are not generally expressed in EBV-positive BL, however their inhibition of BIM is epigenetic and thus heritable, making their continued expression unnecessary in EBV-positive BL [21]. Here, BCL2L11 is linked to Burkitt lymphoma.